Almirall Update: Company Performed Even Better Than Expected in 2024; Rich Medical Dermatology Portfolio and Pipeline
Almirall performed even better than anticipated in 2024 and further grew its European dermatology business, according to a Company press release. The European medical dermatology company surpassed guidance for 2024, achieving net sales of €985.7 million, representing a year-on-year growth of 10.6%. This growth was mainly driven by the strong performance of the European Dermatology business […]